The SunRISe-2 trial evaluating TAR-200 combined with cetrelimab vs chemoradiation in muscle-invasive bladder cancer has been ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on CG Oncology, Inc. (CGON – Research Report). The ...

Analysis by Macmillan estimates that around 60,000 women diagnosed with cancer under the age of 50 are struggling with ...

"Johnson & Johnson discontinues Phase III study of treatment for bladder cancer" was originally created and published by ...

The sun has set on Johnson & Johnson’s SunRISe-2 study. J&J called a halt to the phase 3 bladder cancer trial after an ...

J&J acquired rights to the silicone-based drug delivery service used in TAR-200, which allows for the continuous release of ...

A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S. Johnson & Johnson said on Monday it has discontinued a late-stage ...

The University is part of a nationwide team launching a new platform to understand immunotherapy response and side effects in ...

Lara Stevens says endometriosis is like the cancer she had as a child, with the potential to spread and damage multiple ...

Can you treat prostate cancer? Here is how robotic surgeries can help to stop these malignant cancer cell growths inside the ...